Russia's Vector Centre to Release 2 Variants of COVID-19 Vaccine Into Commercial Turnover

© Sputnik / Vladimir Pesnya / Go to the mediabankRussian COVID-19 Vaccine
Russian COVID-19 Vaccine - Sputnik International
PETROPAVLOVSK-KAMCHATSKY, Russia (Sputnik) - Russia’s Vector research centre plans to release two variants of a COVID-19 vaccine into circulation, said director of the centre Rinat Maksyutov.

"We have developed vaccines for the prevention of COVID-19 on the basis of six independent technological platforms. We have chosen two most promising vaccine options that we intend to release into civic circulation," Maksyutov said in a television appearance on Russia's Rossiya-1 channel.

He went on to posit that some people may develop lifelong immunity under certain conditions.

"With certain characteristics of the immune system, and if the course of the disease was severe, I can assume that lifelong immunity can be formed," Maksyutov said.

The centre's vaccines are not far behind Russian Gamaleya research centre's Sputnik V, which was registered in August.

To participate in the discussion
log in or register
Заголовок открываемого материала